147 related articles for article (PubMed ID: 11061535)
1. Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients.
Colao A; Marzullo P; Spiezia S; Giaccio A; Ferone D; Cerbone G; Di Sarno A; Lombardi G
J Clin Endocrinol Metab; 2000 Oct; 85(10):3754-61. PubMed ID: 11061535
[TBL] [Abstract][Full Text] [Related]
2. Effect of growth hormone (GH) and insulin-like growth factor I on prostate diseases: an ultrasonographic and endocrine study in acromegaly, GH deficiency, and healthy subjects.
Colao A; Marzullo P; Spiezia S; Ferone D; Giaccio A; Cerbone G; Pivonello R; Di Somma C; Lombardi G
J Clin Endocrinol Metab; 1999 Jun; 84(6):1986-91. PubMed ID: 10372698
[TBL] [Abstract][Full Text] [Related]
3. Prostatic hyperplasia: an unknown feature of acromegaly.
Colao A; Marzullo P; Ferone D; Spiezia S; Cerbone G; Marinò V; Di Sarno A; Merola B; Lombardi G
J Clin Endocrinol Metab; 1998 Mar; 83(3):775-9. PubMed ID: 9506725
[TBL] [Abstract][Full Text] [Related]
4. Prostatic disorders in acromegalic patients experience of a Brazilian center.
Corrêa LL; Balarini Lima GA; Cavallieri SA; Miranda LC; Gadelha MR
Int Braz J Urol; 2013; 39(3):393-401. PubMed ID: 23849571
[TBL] [Abstract][Full Text] [Related]
5. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm parameters in men with acromegaly.
Colao A; De Rosa M; Pivonello R; Balestrieri A; Cappabianca P; Di Sarno A; Rochira V; Carani C; Lombardi G
J Clin Endocrinol Metab; 2002 Sep; 87(9):4193-7. PubMed ID: 12213870
[TBL] [Abstract][Full Text] [Related]
6. Effect of GH and/or testosterone deficiency on the prostate: an ultrasonographic and endocrine study in GH-deficient adult patients.
Colao A; Spiezia S; Di Somma C; Marzullo P; Cerbone G; Pivonello R; Faggiano A; Lombardi G
Eur J Endocrinol; 2000 Jul; 143(1):61-9. PubMed ID: 10870032
[TBL] [Abstract][Full Text] [Related]
7. Assessment of disease activity in treated acromegalic patients using a sensitive GH assay: should we achieve strict normal GH levels for a biochemical cure?
Costa AC; Rossi A; Martinelli CE; Machado HR; Moreira AC
J Clin Endocrinol Metab; 2002 Jul; 87(7):3142-7. PubMed ID: 12107214
[TBL] [Abstract][Full Text] [Related]
8. Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Della Morte AM; Pivonello R; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2001 Apr; 86(4):1551-7. PubMed ID: 11297582
[TBL] [Abstract][Full Text] [Related]
9. The relationship between 24-hour growth hormone secretion and insulin-like growth factor I in patients with successfully treated acromegaly: impact of surgery or radiotherapy.
Peacey SR; Toogood AA; Veldhuis JD; Thorner MO; Shalet SM
J Clin Endocrinol Metab; 2001 Jan; 86(1):259-66. PubMed ID: 11232010
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of different biochemical markers of the insulin-like growth factor (IGF) family in diagnosing growth hormone excess and deficiency in adults.
Marzullo P; Di Somma C; Pratt KL; Khosravi J; Diamandis A; Lombardi G; Colao A; Rosenfeld RG
J Clin Endocrinol Metab; 2001 Jul; 86(7):3001-8. PubMed ID: 11443159
[TBL] [Abstract][Full Text] [Related]
11. Severe prostate enlargement with severe lower urinary tract symptoms in poorly controlled acromegaly successfully treated with 5α-reductase inhibitors: A 15-year longitudinal case report.
Chen YC; Chen HW; Chen MT; Huang CH; Li CC; Juan YS; Ke HL
Low Urin Tract Symptoms; 2019 Apr; 11(2):O218-O220. PubMed ID: 29405593
[TBL] [Abstract][Full Text] [Related]
12. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly.
Jenkins PJ; Bates P; Carson MN; Stewart PM; Wass JA
J Clin Endocrinol Metab; 2006 Apr; 91(4):1239-45. PubMed ID: 16403824
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of depot long-acting somatostatin analog Sandostatin LAR in acromegaly.
Colao A; Marzullo P; Ferone D; Spinelli L; Cuocolo A; Bonaduce D; Salvatore M; Boerlin V; Lancranjan I; Lombardi G
J Clin Endocrinol Metab; 2000 Sep; 85(9):3132-40. PubMed ID: 10999798
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1-year treatment with octreotide on cardiac performance in patients with acromegaly.
Colao A; Cuocolo A; Marzullo P; Nicolai E; Ferone D; Florimonte L; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 1999 Jan; 84(1):17-23. PubMed ID: 9920056
[TBL] [Abstract][Full Text] [Related]
15. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-3 levels during early and late follow-up after surgery in acromegalic patients.
Charalampaki P; Hildebrandt G; Schaeffer HJ; Schönau E; Klug N
Exp Clin Endocrinol Diabetes; 1998; 106(2):130-4. PubMed ID: 9628244
[TBL] [Abstract][Full Text] [Related]
17. Acromegalic features in growth hormone (GH)-deficient patients after long-term GH therapy.
Carvalho LR; de Faria ME; Osorio MG; Estefan V; Jorge AA; Arnhold IJ; Mendonca BB
Clin Endocrinol (Oxf); 2003 Dec; 59(6):788-92. PubMed ID: 14974923
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess.
Wiesli P; Zwimpfer C; Zapf J; Schmid C
Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465
[TBL] [Abstract][Full Text] [Related]
19. Hormonal diagnosis of GH hypersecretory states.
Grottoli S; Gasco V; Ragazzoni F; Ghigo E
J Endocrinol Invest; 2003; 26(10 Suppl):27-35. PubMed ID: 15497657
[TBL] [Abstract][Full Text] [Related]
20. The effects of long-term growth hormone and insulin-like growth factor-1 exposure on the development of cardiovascular, cerebrovascular and metabolic co-morbidities in treated patients with acromegaly.
Jayasena CN; Comninos AN; Clarke H; Donaldson M; Meeran K; Dhillo WS
Clin Endocrinol (Oxf); 2011 Aug; 75(2):220-5. PubMed ID: 21521288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
